|Bid||65.22 x 1000|
|Ask||65.25 x 800|
|Day's Range||64.97 - 66.39|
|52 Week Range||36.12 - 66.39|
|Beta (5Y Monthly)||0.93|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 06, 2021|
|Forward Dividend & Yield||0.40 (0.60%)|
|Ex-Dividend Date||Mar 25, 2021|
|1y Target Est||66.93|
The updated first-half 2021 outlook by Quest Diagnostics (DGX) looks impressive given its raised revenue and operating cash flow expectations.
Intuitive Surgical's (ISRG) first-quarter results reflect strong segmental performance.
Abbott (ABT) reports strong Diagnostics sales for the first quarter driven by growing demand for its BinaxNOW, Panbio and ID NOW rapid testing platforms.